|
|
Volumn 14, Issue 2, 2005, Pages 81-84
|
|
A randomised open-label study of tiagabine given two or three times daily in refractory epilepsy
a
b
c
d
e
f
g
h
i
a
HOSPITAL CLÍNIC
(Spain)
|
|
Author keywords
Anticonvulsant; Antiepileptic drugs; Drug administration; Epilepsy; Seizures; Tiagabine
|
|
Indexed keywords
TIAGABINE;
ADOLESCENT;
ADULT;
AMBLYOPIA;
AMNESIA;
ARTICLE;
ASTHENIA;
ATAXIA;
CLINICAL TRIAL;
CONFUSION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEPRESSION;
DISEASE CONTROL;
DISEASE SEVERITY;
DIZZINESS;
DOSE RESPONSE;
DRUG DOSE REGIMEN;
DRUG EFFICACY;
DRUG TOLERABILITY;
EPILEPTIC STATE;
FEMALE;
FOCAL EPILEPSY;
HEADACHE;
HUMAN;
INCIDENCE;
INFECTION;
INTERMETHOD COMPARISON;
LONG TERM CARE;
MAINTENANCE THERAPY;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
MYOCLONUS;
NAUSEA;
PHARYNGITIS;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SOMNOLENCE;
TITRIMETRY;
TREATMENT OUTCOME;
TREMOR;
ANTICONVULSANTS;
CHILD;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
DRUG RESISTANCE;
DRUG TOLERANCE;
EPILEPSY;
FEMALE;
HUMANS;
MALE;
NIPECOTIC ACIDS;
|
|
EID: 13444271012
PISSN: 10591311
EISSN: None
Source Type: Journal
DOI: 10.1016/j.seizure.2004.09.002 Document Type: Article |
|
Times cited : (11)
|
|
References (4)
|
